Demographic Characteristics Associated With Intentions to Receive the 2023–2024 COVID-19 Vaccine

Lee, Ryan C.; Sood, Neeraj; Lam, Chun Nok; Unger, Jennifer B.

doi:10.1016/j.amepre.2024.02.005

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our study, various socio-demographic traits were found to be associated with vaccine hesitancy. As shown in other studies, being female was found to increase the likelihood of vaccine hesitancy [36,43,[51][52][53][54][55][56][57][58]. Older age, especially in the range of 50-64 years, also played a significant negative role in determining patient acceptance of the COVID-19 vaccine, which is similar to other studies [40,41,52].…”

Section: Discussionsupporting

confidence: 87%

The Prevalence and Determinants of Hesitancy for Regular COVID-19 Vaccination among Primary Healthcare Patients with Asthma or COPD in Greece: A Cross-Sectional Study

Bouloukaki,

Christodoulakis,

Papageorgakopoulou

et al. 2024

Vaccines

View full text Add to dashboard Cite

The emergence of novel coronavirus mutations and signs of the waning immunity provided by COVID-19 vaccines underscore the importance of regular vaccination. This study aimed to investigate the prevalence of regular COVID-19 vaccination hesitancy and the factors that influence it among patients with asthma or chronic obstructive pulmonary disease (COPD) who visited primary care centers. The cross-sectional study was conducted in six primary healthcare centers in Crete, Greece (October–December 2023). Participants completed a questionnaire, which included questions about socio-demographic characteristics, health status, previous COVID-19 booster vaccination, attitudes, and beliefs about COVID-19 vaccination. Multivariate logistic regression was used to identify the factors that influenced vaccine hesitancy. Of the 264 participants, 65% exhibited hesitancy towards COVID-19 booster vaccination. Female gender, middle age, lower educational attainment, depression diagnosis, concerns about vaccine side effects, lack of confidence in vaccine efficacy, and reliance on media information were positively associated to vaccine hesitancy. Conversely, those having a cardiovascular disease or type 2 diabetes, those generally adhering to the recommendations of the treating physician, and those having previously received the flu vaccine or more than three COVID-19 vaccine doses were positively associated with regular COVID-19 vaccinations. Consequently, our findings could help develop strategies that could potentially reduce regular vaccination hesitancy among patients with asthma or COPD.

show abstract